Your browser doesn't support javascript.
loading
Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M.
Abe, Hajime; Takeda, Norihiko; Isagawa, Takayuki; Semba, Hiroaki; Nishimura, Satoshi; Morioka, Masaki Suimye; Nakagama, Yu; Sato, Tatsuyuki; Soma, Katsura; Koyama, Katsuhiro; Wake, Masaki; Katoh, Manami; Asagiri, Masataka; Neugent, Michael L; Kim, Jung-Whan; Stockmann, Christian; Yonezawa, Tomo; Inuzuka, Ryo; Hirota, Yasushi; Maemura, Koji; Yamashita, Takeshi; Otsu, Kinya; Manabe, Ichiro; Nagai, Ryozo; Komuro, Issei.
Afiliação
  • Abe H; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Takeda N; The School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, London, SE5 9NU, UK.
  • Isagawa T; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. ntakeda-tky@umin.ac.jp.
  • Semba H; PRESTO, JST, 4-1-8 Honcho Kawaguchi, Saitama, 332-0012, Japan. ntakeda-tky@umin.ac.jp.
  • Nishimura S; Graduate School of Biomedical Science, Nagasaki University, 1-7-1sakamoto, Nagasaki, 852-8501, Japan.
  • Morioka MS; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Nakagama Y; Department of Cardiovascular Medicine, The Cardiovascular Institute, 3-2-19 Nishiazabu, Minato-ku, Tokyo, 106-00031, Japan.
  • Sato T; PRESTO, JST, 4-1-8 Honcho Kawaguchi, Saitama, 332-0012, Japan.
  • Soma K; Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan.
  • Koyama K; Depertment of Bioinformatics, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyoku, Tokyo, 113-8510, Japan.
  • Wake M; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Katoh M; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Asagiri M; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Neugent ML; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Kim JW; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Stockmann C; Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Yonezawa T; Department of Pathobiology, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, 467-8603, Japan.
  • Inuzuka R; Department of Biological Sciences, The University of Texas at Dallas, 800W. Campbell Road FO 3.704G, Richardson, TX, 75080, USA.
  • Hirota Y; Department of Biological Sciences, The University of Texas at Dallas, 800W. Campbell Road FO 3.704G, Richardson, TX, 75080, USA.
  • Maemura K; Institute of Anatomy, University of Zurich, Zurich, CH-8057, Switzerland.
  • Yamashita T; Cancer Research Center Zurich, Winterthurerstrasse 190, CH-8057, Zurich, Switzerland.
  • Otsu K; Center for Therapeutic Innovation, Gene Research Center, Center for Frontier Life Sciences, Nagasaki University, Graduate School of Biomedical Sciences, 1-12-14 Sakamoto, Nagasaki, 852-8523, Japan.
  • Manabe I; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Nagai R; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Komuro I; Graduate School of Biomedical Science, Nagasaki University, 1-7-1sakamoto, Nagasaki, 852-8501, Japan.
Nat Commun ; 10(1): 2824, 2019 06 27.
Article em En | MEDLINE | ID: mdl-31249305
ABSTRACT
The fibrogenic response in tissue-resident fibroblasts is determined by the balance between activation and repression signals from the tissue microenvironment. While the molecular pathways by which transforming growth factor-1 (TGF-ß1) activates pro-fibrogenic mechanisms have been extensively studied and are recognized critical during fibrosis development, the factors regulating TGF-ß1 signaling are poorly understood. Here we show that macrophage hypoxia signaling suppresses excessive fibrosis in a heart via oncostatin-m (OSM) secretion. During cardiac remodeling, Ly6Chi monocytes/macrophages accumulate in hypoxic areas through a hypoxia-inducible factor (HIF)-1α dependent manner and suppresses cardiac fibroblast activation. As an underlying molecular mechanism, we identify OSM, part of the interleukin 6 cytokine family, as a HIF-1α target gene, which directly inhibits the TGF-ß1 mediated activation of cardiac fibroblasts through extracellular signal-regulated kinase 1/2-dependent phosphorylation of the SMAD linker region. These results demonstrate that macrophage hypoxia signaling regulates fibroblast activation through OSM secretion in vivo.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose / Oncostatina M / Macrófagos / Hipóxia Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose / Oncostatina M / Macrófagos / Hipóxia Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão